Neuland Laboratories Ltd. benchmarking: Performance to industry peers

Financial

	Neuland Laboratories	Gufic Biosciences	Alivus Life Sciences
Operational Metrics
Pharmaceuticals
US DMF Filings	75.0 .	n/a	611.0 .
Global DMFs filed	1007.0 .	n/a	n/a
Total reactor capacity	1226.0 kL	n/a	n/a
R&D as a % of Total Sales	4.15 %	1.28 %	3.6 %
Financials
5 yr Average ROE	16.78 %	16.89 %	25.27 %
5yr average Equity Multiplier	1.53	2.16	1.74
5yr Average Asset Turnover Ratio	0.73	0.75	0.71
5yr Avg Net Profit Margin	15.06 %	10.24 %	20.19 %
Price to Book	12.85	5.85	4.29
P/E	66.17	60.58	25.31
5yr Avg Cash Conversion Cycle	32.22 Days	-15.25 Days	100.66 Days
Inventory Days	85.47 Days	71.73 Days	95.06 Days
Days Receivable	77.32 Days	106.89 Days	132.12 Days
Days Payable	121.04 Days	179.29 Days	120.47 Days
5yr Average Interest Coverage Ratio	23.69	8.9	371.82
5yr Avg ROCE	19.67 %	17.89 %	33.88 %
5yr Avg Operating Profit Margin	23.56 %	18.12 %	29.64 %
5 yr average Debt to Equity	0.13	0.67	0.0
5yr CAGR Net Profit	41.65 %	-2.66 %	6.67 %
5yr Average Return on Assets	11.14 %	7.7 %	14.28 %
Shareholdings
Promoter Holding	32.63 %	72.5 %	74.87 %
Share Pledged by Promoters	2.29 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-3.51 %	-2.5 %	-7.98 %
Change in Mutual Fund Holding (3 Yrs)	10.36 %	2.6 %	5.13 %

Business

	Neuland Laboratories	Gufic Biosciences	Alivus Life Sciences
Product Wise Break-Up	Product Wise Break-Up Formulations 76.0 Custom Manufacturing Solutions(CMS) 18.0 API 0 Muscle Relaxants 0 Cardiovascular 0 Proton pump inhibitors 0 Anti-fungals 0 Anti-bacterials 0 International 0 CMO 0 Domestic 0 API`s 0 CDMO 0 Generic API 0 Others 6.0	Product Wise Break-Up Domestic Pharmaceuticals 50.0 Custom Manufacturing Solutions(CMS) 0 CMO 30.0 CDMO 0 Active Pharmaceutical Ingredient (API) 5.0 Anti-fungals 0 API`s 0 Formulations 0 International 15.0 Cardiovascular 0 Anti-bacterials 0 Proton pump inhibitors 0 Muscle Relaxants 0 Generic API 0	Product Wise Break-Up Domestic 0 Custom Manufacturing Solutions(CMS) 0 CMO 0 CDMO 6.57 API 0 Anti-fungals 0 API`s 0 Formulations 0 International 0 Cardiovascular 0 Anti-bacterials 0 Proton pump inhibitors 0 Muscle Relaxants 0 Generic API 92.05 Others 1.38
Location Wise Break-Up	Location Wise Break-Up India 30.39 Europe 29.86 USA 29.35 Rest of the World 10.4 South America 0 Australia 0 North America 0 Asia 0 Africa 0	Location Wise Break-Up USA 0 Asia Pacific 6.04 India 79.83 Rest of the World 0 South America 2.37 Europe 7.54 Australia 0.08 North America 1.19 Africa 2.95	Location Wise Break-Up USA 0 Asia 0 India 48.28 Rest of the World 0 South America 0 Europe 0 Australia 0 North America 0 Africa 0 Others 51.72
Therapeutic Area Break-Up	Therapeutic Area Break-Up Anti-bacterial 19.72 Antidepressant 11.8 Anticonvulsant 10.46 Pain Management 0 Diabetes 0 CNS 0 CVS 0 Others 58.02	-	Therapeutic Area Break-Up Diabetes 4.0 Anticonvulsant 0 Anti-bacterial 0 CVS 42.0 Antidepressant 0 Pain Management 4.0 CNS 14.0 Others 36.0
Asset Break-Up	Asset Break-Up India 100.0	-	-

Neuland Laboratories Ltd.

Neuland Laboratories Ltd.

Financial

Business

SIGN UP FOR FREE